文献速递乳腺MR乳腺X线

评估筛查性乳腺X线摄影对接受筛查性乳腺MR成像的高危女性的效用

Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
PubMed 文献 · Radiology · 2017-06-06

该研究回顾性分析了1249例高危女性在2012年1月至2014年7月间进行的1977次筛查MR成像和1957次筛查乳腺X线摄影,共诊断45例乳腺癌,其中MR检出43例、乳腺X线摄影检出14例。MR的癌症检出率、敏感度均高于乳腺X线摄影,而特异度低于乳腺X线摄影。结论认为同期筛查乳腺X线摄影对接受筛查MR成像的女性未提供附加检出价值,常规使用筛查乳腺X线摄影需重新考虑。

要点

  • 高危女性筛查中MR检出43/45例癌症,乳腺X线摄影仅检出14例。
  • MR癌症检出率21.8/1000次检查,乳腺X线摄影为7.2/1000次检查(P < .001)。
  • MR敏感度96%、特异度78%;乳腺X线摄影敏感度31%、特异度89%(P < .001)。

核心结论

  • 同期筛查乳腺X线摄影对接受筛查MR成像的女性在乳腺癌检出方面未显示附加价值。
  • 作者认为在接受筛查性乳腺MR成像的女性中常规使用筛查乳腺X线摄影值得重新考虑。

研究设计与样本

  • 经伦理批准的回顾性研究,对前瞻性数据库进行回顾,纳入1249例高危女性。
  • 2012年1月至2014年7月间共3934次筛查检查,包括1977次筛查MR成像和1957次筛查乳腺X线摄影。
  • 计算了乳腺X线摄影和MR成像的召回率、癌症检出率、敏感度、特异度及阳性预测值。

诊断标准与关键数值

  • MR成像召回率23.3%(95%CI:21.5%,25.2%),乳腺X线摄影召回率11.1%(95%CI:9.7%,12.6%)。
  • MR成像癌症检出率21.8/1000次检查(95%CI:15.78,29.19),乳腺X线摄影7.2/1000次检查(95%CI:3.92,11.97;P < .001)。
  • MR成像敏感度96%、特异度78%;乳腺X线摄影敏感度31%、特异度89%(P < .001)。
  • MR成像召回的阳性预测值9.3%(95%CI:6.83%,12.36%),乳腺X线摄影召回的阳性预测值6.5%(95%CI:3.57%,10.59%)。

临床应用与阅片要点

  • 原文结论认为同期筛查乳腺X线摄影在高危女性中未提供附加检出价值,常规使用值得重新考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the value of mammography in detecting breast cancer in high-risk women undergoing screening breast magnetic resonance (MR) imaging. Materials and Methods An ethics-approved, retrospective review of prospective databases was performed to identify outcomes of 3934 screening studies (1977 screening MR imaging examinations and 1957 screening mammograms) performed between January 2012 and July 2014 in 1249 high-risk women. Performance measures including recall and cancer detection rates, sensitivity, specificity, and positive predictive values were calculated for both mammography and MR imaging. Results A total of 45 cancers (33 invasive and 12 ductal carcinomas in situ) were diagnosed, 43 were seen with MR imaging and 14 with both mammography and MR imaging. Additional tests (further imaging and/or biopsy) were recommended in 461 screening MR imaging studies (recall rate, 23.3%; 95% confidence interval [CI]: 21.5%, 25.2%), and mammography recalled 217 (recall rate, 11.1%; 95% CI: 9.7%, 12.6%). The cancer detection rate for MR imaging was 21.8 cancers per 1000 examinations (95% CI: 15.78, 29.19) and that for mammography was 7.2 cancers per 1000 examinations (95% CI: 3.92, 11.97; P < .001). Sensitivity and specificity of MR imaging were 96% and 78% respectively, and those of mammography were 31% and 89%, respectively (P < .001). Positive predictive value for MR imaging recalls was 9.3% (95% CI: 6.83%, 12.36%) and that for mammography recalls was 6.5% (95% CI: 3.57%, 10.59%). Conclusion Contemporaneous screening mammography did not have added value in detection of breast cancer for women who undergo screening MR imaging. Routine use of screening mammography in women undergoing screening breast MR imaging warrants reconsideration. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lo G, Scaranelo AM, Aboras H, et al. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging. Radiology. 2017. PMID: 28586291. doi:10.1148/radiol.2017161103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。